835TiP - Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO

S Lorenzen,C Pauligk,T.O Goetze,J Riera Knorrenschild,E Goekkurt,F Kullmann,D Pink,T.J Ettrich,N Homann,S Angermeier,P.C Thuss-Patience,U Lindig,M Bitzer,T Dechow,G Schuch,H Schmalenberg,S Junge,R.D Hofheinz,S.-E Al-Batran

doi:10.1093/annonc/mdz247.161

Abstract

835TiP - Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Moonlight, a randomized phase II trial of the German Gastric Group of the AIO

Full Text